MISSLING CHRISTOPHER U 4
4 · ANAVEX LIFE SCIENCES CORP. · Filed Sep 12, 2025
Insider Transaction Report
Form 4
MISSLING CHRISTOPHER U
DirectorPresident and CEO
Transactions
- Exercise/Conversion
Common Stock
2025-09-11$5.04/sh+187,500$945,000→ 1,655,213 total - Tax Payment
Common Stock
2025-09-11$9.58/sh−145,048$1,389,560→ 1,510,165 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-09-11−187,500→ 0 totalExercise: $5.04From: 2018-09-18Exp: 2025-09-18→ Common Stock (187,500 underlying)
Footnotes (1)
- [F1]Represents a "net exercise" of outstanding stock options, which options were scheduled to expire on September 18, 2025. The reporting person received 42,452 shares of common stock on net exercise of an option to purchase 187,500 shares of common stock. The Company withheld 145,048 shares of common stock underlying the option as consideration for the exercise price and tax withholdings, using the closing price on September 11, 2025 of $9.58, pursuant to the terms of the Company's 2015 Stock Option Plan.